These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 37513627)

  • 21. Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients.
    Genazzani AD; Battipaglia C; Rusce L; Prampolini G; Aio C; Ricciardiello F; Foschi M; Sponzilli A; Semprini E; Petrillo T
    Gynecol Endocrinol; 2024 Dec; 40(1):2341701. PubMed ID: 38622970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inositol for subfertile women with polycystic ovary syndrome.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hodgson R; Farquhar C
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012378. PubMed ID: 30570133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
    Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
    Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
    Zhang J; Xing C; Cheng X; He B
    Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
    Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
    Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
    Pustotina O; Myers SH; Unfer V; Rasulova I
    Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS).
    Valsamakis G; Lois K; Kumar S; Mastorakos G
    Hormones (Athens); 2013; 12(3):363-78. PubMed ID: 24121378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome.
    Nazirudeen R; Sridhar S; Priyanka R; Sumathi B; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
    Clin Endocrinol (Oxf); 2023 Aug; 99(2):198-205. PubMed ID: 37265016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
    Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
    J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Morgante G; Massaro MG; Di Sabatino A; Cappelli V; De Leo V
    Gynecol Endocrinol; 2018 Jan; 34(1):4-9. PubMed ID: 28850273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future.
    Laganà AS; Myers SH; Forte G; Naem A; Krentel H; Allahqoli L; Alkatout I; Unfer V
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):61-72. PubMed ID: 38226638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome.
    Banaszewska B; Pawelczyk L; Spaczynski R
    Reprod Biol; 2019 Dec; 19(4):309-315. PubMed ID: 31606349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome - A randomized controlled trial.
    Andavar M; Kamaraj R; Mahalingam Vijayakumar T; Murugesan A
    Eur J Obstet Gynecol Reprod Biol; 2024 Sep; 300():6-11. PubMed ID: 38972164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inositol as putative integrative treatment for PCOS.
    Genazzani AD
    Reprod Biomed Online; 2016 Dec; 33(6):770-780. PubMed ID: 27717596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.
    Rago R; Marcucci I; Leto G; Caponecchia L; Salacone P; Bonanni P; Fiori C; Sorrenti G; Sebastianelli A
    J Biol Regul Homeost Agents; 2015; 29(4):913-23. PubMed ID: 26753656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
    Bader S; Bhatti R; Mussa B; Abusanana S
    Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial.
    Jethaliya H; Gajjar N; Patel V; Deshpande S; Patel R
    Reprod Sci; 2022 Aug; 29(8):2282-2298. PubMed ID: 35477841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial.
    Wen Q; Hu M; Lai M; Li J; Hu Z; Quan K; Liu J; Liu H; Meng Y; Wang S; Wen X; Yu C; Li S; Huang S; Zheng Y; Lin H; Liang X; Lu L; Mai Z; Zhang C; Wu T; Ng EHY; Stener-Victorin E; Ma H
    Hum Reprod; 2022 Mar; 37(3):542-552. PubMed ID: 34907435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.